Quantcast
Last updated on April 20, 2014 at 0:02 EDT

Latest Tianyin Pharmaceutical Co. Inc. Stories

2010-11-08 10:00:00

CHENGDU, China, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a pharmaceutical company that develops, manufactures and sells patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced that the senior management will host the earnings conference call for the first quarter of fiscal year 2011 ending September 30, 2010 at 9:00 a.m. ET on Thursday, November 11, 2010....

2010-11-08 04:00:00

CHENGDU, China, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Lazard Capital Markets 7th Annual Healthcare Conference from November 16 - 17, 2010 at the St. Regis Hotel in New York. Dr. James Jiayuan Tong, Tianyin's Chief Financial Officer, Chief Business &...

2010-11-02 01:00:00

CHENGDU, China, Nov. 2, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will present at the 2010 Maxim Group Growth Conference on Thursday November 18, 2010 at the Grand Hyatt Hotel in New York, NY. Dr. James Jiayuan Tong, Tianyin's Chief Financial Officer, Chief Business &...

2010-09-29 07:46:00

CHENGDU, China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ("TCM"), branded generics and other pharmaceuticals, announced the results of fiscal year 2010 ended June 30, 2010. Fiscal year 2010 ending June 30, 2010 financial highlights -- FY2010 revenue exceeds our revenue guidance of $63.0 million for FY2010,...

2010-09-27 13:00:00

CHENGDU, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that develops, manufactures and markets patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced that the senior management will host a conference call to discuss its fiscal year 2010 results at 9:00 a.m. ET on Thursday, September 30, 2010. Interested parties may access the call...

2010-09-23 12:00:00

CHENGDU, China, Sept. 23 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in modernized traditional Chinese medicine, branded generics and other pharmaceuticals, publishes the updated corporate presentation which was presented at 2010 Roth Hawaii Conference and Rodman & Renshaw 2010 Annual Global Investment Conference in September at the Company's website: www.tianyinpharma.com About Tianyin Pharmaceutical...

2010-09-08 19:00:00

CHENGDU, China, Sept. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics will participate in the Rodman & Renshaw 2010 Annual Global Investment Conference at the New York Palace Hotel from September 12 till September 15, 2010. Presenter: Dr. James Jiayuan Tong, Title: Chief Financial Officer, Chief...

2010-08-30 13:30:00

CHENGDU, China, Aug. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics will participate in the Roth Fall Conference from September 1 - September 6 at Grand Wailea Resort Hotel, Maui, Hawaii. Dr. James Jiayuan Tong, Tianyin's Chief Financial Officer, Chief Business & Development Officer and Director is...

2010-07-16 12:00:00

CHENGDU, China, July 16 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics provides progress update on its Jiangchuan macrolide facility. The construction of the facility is on schedule, targeting August for completion and equipment installation, immediately followed by GMP certification and trial production. The state-of-the-art...

2010-06-28 09:00:00

CHENGDU, China, June 28 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics will exhibit and promote its flagship product portfolio at the 45th 2010 National New Special Drugs Trade Fair at Beijing National Convention Center from July 8th, till July 10th. Tianyin's portfolio is featured by the patented Ginkgo Mihuan Oral Liquid (GMOL)...